No Azithromycine for CVD Risk Patients

german translation / full article

An observational study shows a small absolute increase in cardiovascular deaths in patients on a 5 day azithromycin regimen (most pronounced among patients with a high baseline risk of cardiovascular disease). Prescribing should be reconsidered in


(State: 17.10.2012)

Latest Issue 10/2012

In Focus

  • Versus Good of the Individual “… I Never Thought About This” – Qualitative Results of a Mixed-Methods Study on Antibiotic Prescribing for Urinary Tract Infections
  • “Heparin until Walking without a Limp”? – Prevention of Venous Thromboembolism in Case of Arthroplasty of the Hip or Knee, Injury of the Leg and Long Traveling: a Case for a Shared Decision
  • Leg Edema: Differential Diagnostics in Family Practice